Facultade de Medicina e Odontoloxía
Facultad
University of Szeged
Szeged, HungríaPublicacións en colaboración con investigadores/as de University of Szeged (82)
2024
-
Evidence-based definition of hypoprolactinemia in European men aged 40–86 years: the European male ageing study
Reviews in Endocrine and Metabolic Disorders
-
Hyponatremia, hypernatremia and impairment of functional, psychological and sexual domains
Journal of Endocrinological Investigation, Vol. 47, Núm. 4, pp. 1005-1014
-
Insulin-like peptide 3 (INSL3) as an indicator of leydig cell insufficiency (LCI) in Middle-aged and older men with hypogonadism: reference range and threshold
Aging Male, Vol. 27, Núm. 1
2023
-
Does testosterone influence the association between sleep and frailty in men: results from the European Male Aging Study
BMC Geriatrics, Vol. 23, Núm. 1
-
Sarcopenia-defining parameters, but not sarcopenia, are associated with cognitive domains in middle-aged and older European men
Journal of Cachexia, Sarcopenia and Muscle, Vol. 14, Núm. 3, pp. 1520-1532
2022
-
Association of age, hormonal, and lifestyle factors with the Leydig cell biomarker INSL3 in aging men from the European Male Aging Study cohort
Andrology, Vol. 10, Núm. 7, pp. 1328-1338
-
Reproductive hormone levels, androgen receptor CAG repeat length and their longitudinal relationships with decline in cognitive subdomains in men: The European Male Ageing Study.
Physiology and Behavior, Vol. 252
-
The Leydig cell biomarker INSL3 as a predictor of age-related morbidity: Findings from the EMAS cohort
Frontiers in Endocrinology, Vol. 13
2021
-
Inflammatory markers are associated with quality of life, physical activity, and gait speed but not sarcopenia in aged men (40–79 years)
Journal of Cachexia, Sarcopenia and Muscle, Vol. 12, Núm. 6, pp. 1818-1831
-
Self-Reported Shorter Than Desired Ejaculation Latency and Related Distress—Prevalence and Clinical Correlates: Results From the European Male Ageing Study
Journal of Sexual Medicine, Vol. 18, Núm. 5, pp. 908-919
2019
-
Antibiotic therapy in acute pancreatitis: From global overuse to evidence based recommendations
Pancreatology, Vol. 19, Núm. 4, pp. 488-499
2018
-
Elevated luteinizing hormone despite normal testosterone levels in older men—natural history, risk factors and clinical features
Clinical Endocrinology, Vol. 88, Núm. 3, pp. 479-490
-
Reproductive hormone levels predict changes in frailty status in community-dwelling older men: European male ageing study prospective data
Journal of Clinical Endocrinology and Metabolism, Vol. 103, Núm. 2, pp. 701-709
-
Symptomatic androgen deficiency develops only when both total and free testosterone decline in obese men who may have incident biochemical secondary hypogonadism: Prospective results from the EMAS
Clinical Endocrinology, Vol. 89, Núm. 4, pp. 459-469
2017
-
Changes in prevalence of obesity and high waist circumference over four years across European regions: the European male ageing study (EMAS)
Endocrine, Vol. 55, Núm. 2, pp. 456-469
-
Evaluation of cognitive subdomains, 25-hydroxyvitamin D, and 1,25-dihydroxyvitamin D in the European Male Ageing Study
European Journal of Nutrition, Vol. 56, Núm. 6, pp. 2093-2103
-
Frailty and bone health in European men
Age and Ageing, Vol. 46, Núm. 4, pp. 635-641
-
Glycemia but not the Metabolic Syndrome is Associated with Cognitive Decline: Findings from the European Male Ageing Study
American Journal of Geriatric Psychiatry, Vol. 25, Núm. 6, pp. 662-671
-
Nonandrogenic anabolic hormones predict risk of frailty: European male ageing study prospective data
Journal of Clinical Endocrinology and Metabolism, Vol. 102, Núm. 8, pp. 2798-2806
2016
-
Chronic widespread pain is associated with worsening frailty in European men
Age and Ageing, Vol. 45, Núm. 2, pp. 268-274